NEW YORK, April 27, 2026 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP reminds purchasers of Nektar Therapeutics (NASDAQ. NKTR) securities of a pending securities class action ... .
Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Nektar Therapeutics ("Nektar" or the "Company") (NASDAQ.
Why. Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Nektar Therapeutics (NASDAQ... To join the Nektar class action, go to https.//rosenlegal.com/submit-form/?case_id=55599 or call Phillip Kim, Esq.
LOS ANGELES, April 24, 2026 (GLOBE NEWSWIRE) -- Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming May 5, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased ... .
) UNITED STATES. SECURITIES AND EXCHANGE COMMISSION. Washington, D.C. 20549. SCHEDULE 14A ... (Amendment No. ) ... Nektar Therapeutics ... Nektar Therapeutics published this content on April 24, 2026, and is solely responsible for the information contained herein.